Dihexa
Angiotensin IV analog studied in synaptogenesis research.
Evidence Level
Emerging
Research Type
/ System Mapping
Where this compound appears in research pathways
Research-only note: This mapping is educational and does not represent a treatment protocol.
/ 01
Overview
Angiotensin IV analog studied in synaptogenesis research.
/ 02
Mechanism of Action
Studied for HGF/c-Met signaling and dendritic spine formation.
/ 03
Research Applications
Cognitive enhancement and neural plasticity research.
Studied for, research explores, preclinical models suggest, clinical studies have investigated.
/ 04
Studied Research Contexts
/ 05
Studied Research Dosing Ranges
Limited public data on dosing ranges across research models.
/ 06
Potential Adverse Effects Reported in Research
Adverse effect data is limited. Many compounds in this database lack human safety profiles.
/ 07
Mechanism Deep Dive
Dihexa is an angiotensin IV-derived compound. Preclinical research describes interaction with HGF/c-Met signaling and reported synaptogenic activity in cell and rodent models.
/ 08
Pathway Role
Sits within HGF/c-Met signaling and synaptogenesis pathways in preclinical neural models.
/ 09
Biological Targets
/ 10
Research Applications
- Cognitive function preclinical studies
- Synaptogenesis mechanism research
/ 11
Evidence Summary
Preclinical evidence only. No established human outcome data.
Evidence Level Rationale
Rated preclinical/emerging due to absence of human controlled trials.
/ 12
Research Observation Timeline
Early Signal Window
Cellular synaptogenic markers within hours to days in vitro
Primary Study Window
Days to weeks in preclinical models
Endpoint Type
Cellular and behavioral preclinical endpoints
Evidence Strength
Preclinical only
/ 13
Safety & Unknowns
Human safety profile is not characterized in published controlled studies.
/ 14
Research Limitations
Translation from preclinical synaptogenic mechanism to human outcomes is not established.
/ 15
References
References are being curated from peer-reviewed literature.
/ 07
Evidence Score
Overall Research Confidence
Emerging
Reflects breadth of mechanism, study type, and reproducibility across research literature.
/ 08
Related Peptides
Semax
Synthetic ACTH(4-10) analog studied in neurotrophic research.
Selank
Synthetic tuftsin analog studied in anxiolytic-like research.
Cerebrolysin
Neuropeptide preparation studied in neuroregeneration research.
Appears in pathways
For research and educational purposes only.
Not medical advice. Not intended to diagnose, treat, cure, or prevent disease. Compounds discussed may not be approved for human use. Any dosing information shown describes ranges studied in research settings — never a recommendation.